Paradigm Financial Advisors’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
Paradigm Financial Advisors's GILD Position: Q1 2018 in Review
Paradigm Financial Advisors sold out of Gilead Sciences (GILD) in Q1 2018, closing a stake of 4,947 shares — an estimated $354K sold.
Paradigm Financial Advisors first reported a position in GILD in Q3 2014 and held it in 14 quarters. The position peaked at $5.52M in Q4 2015. 1,563 funds tracked by Wall St. Rank hold GILD as of Q1 2018.
- Paradigm Financial Advisors reported no remaining Gilead Sciences position as of Q1 2018 after selling out during the quarter.
- Paradigm Financial Advisors sold 4,947 Gilead Sciences shares in Q1 2018, an estimated $354K.
- Paradigm Financial Advisors first reported a position in Gilead Sciences in Q3 2014 and held it in 14 quarters.
- Paradigm Financial Advisors's Gilead Sciences position peaked at $5.52M in Q4 2015.
- 1,563 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2018.
Based on Paradigm Financial Advisors's 13F filing for Q1 2018, filed 2 May 2018.